McKesson Cash Flow from Financial Activities 2012-2026 | MCK
McKesson annual/quarterly cash flow from financial activities history and growth rate from 2012 to 2026. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- McKesson cash flow from financial activities for the quarter ending March 31, 2026 was $-1.811B, a 63.15% increase year-over-year.
- McKesson cash flow from financial activities for the twelve months ending March 31, 2026 was $-4.385B, a 42.82% decline year-over-year.
- McKesson annual cash flow from financial activities for 2025 was $-3.965B, a 18.64% increase from 2024.
- McKesson annual cash flow from financial activities for 2024 was $-3.342B, a 23.49% decline from 2023.
- McKesson annual cash flow from financial activities for 2023 was $-4.368B, a 30.9% decline from 2022.
|
McKesson Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2025 | $-3,965 |
| 2024 | $-3,342 |
| 2023 | $-4,368 |
| 2022 | $-6,321 |
| 2021 | $-1,693 |
| 2020 | $-2,734 |
| 2019 | $-2,227 |
| 2018 | $-3,084 |
| 2017 | $-2,069 |
| 2016 | $-3,453 |
| 2015 | $-968 |
| 2014 | $3,619 |
| 2013 | $-956 |
| 2012 | $-1,905 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $106.025B | $359.051B |
| McKesson Corporation distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. The Company also develops, implements and supports software which facilitates the integration of data throughout the health enterprise. McKesson Corporation is based in IRVING, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |